Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Assayag

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Chest|March 1, 2014
Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic reviewTiffany A Winstone, Deborah Assayag, Pearce G Wilcox, et al.
American Journal of Respiratory and Critical Care Medicine|March 27, 2024
Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung DiseaseYet H Khor, Kerri A Johannson, Veronica Marcoux, et al.
Respiratory Medicine|May 5, 2018
Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary diseaseNafiseh Naderi, Deborah Assayag, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
Respirology (Carlton, Vic.)|June 2, 2022
Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung diseaseBoyang Zheng, Kathryn Donohoe, Nathan Hambly, et al.
Chest|September 11, 2022
Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter StudyYet H Khor, Malik Farooqi, Nathan Hambly, et al.
Chest|April 26, 2020
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 PandemicAlyson W Wong, Lee Fidler, Veronica Marcoux, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease associationLydia Ouchene, Anastasiya Muntyanu, Deborah Assayag, et al.
The European Respiratory Journal|November 7, 2024
Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosisYet H Khor, Kerri A Johannson, Veronica Marcoux, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Respiratory Medicine|March 10, 2022
Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILDMichele R Schaeffer, Divjot S Kumar, Deborah Assayag, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Chest|March 1, 2014
Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic reviewTiffany A Winstone, Deborah Assayag, Pearce G Wilcox, et al.
American Journal of Respiratory and Critical Care Medicine|March 27, 2024
Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung DiseaseYet H Khor, Kerri A Johannson, Veronica Marcoux, et al.
Respiratory Medicine|May 5, 2018
Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary diseaseNafiseh Naderi, Deborah Assayag, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
Respirology (Carlton, Vic.)|June 2, 2022
Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung diseaseBoyang Zheng, Kathryn Donohoe, Nathan Hambly, et al.
Chest|September 11, 2022
Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter StudyYet H Khor, Malik Farooqi, Nathan Hambly, et al.
Chest|April 26, 2020
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 PandemicAlyson W Wong, Lee Fidler, Veronica Marcoux, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease associationLydia Ouchene, Anastasiya Muntyanu, Deborah Assayag, et al.
The European Respiratory Journal|November 7, 2024
Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosisYet H Khor, Kerri A Johannson, Veronica Marcoux, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Respiratory Medicine|March 10, 2022
Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILDMichele R Schaeffer, Divjot S Kumar, Deborah Assayag, et al.
Pageof 7